WebApr 26, 2024 · hemotune AG, a spin-off from ETH Zurich founded in 2024 and being accelerated by Wyss Zurich, today announced the closing of a CHF 7.25 million Series B1 for the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. The investment consortium was led by OCCIDENT … WebOct 27, 2024 · hemotune is a MedTech start-up based in Schlieren, Switzerland, developing a revolutionary blood purification platform. This combines cutting-edge scientific results from biomedicine and nanotechnology to develop the HemoSystem, a new treatment platform that combines the benefits of medical devices and biotechnology.
Partnerschaft macht Dividats Reha-Gerät senso weltweit zugänglich
WebCarlos Mora is one of the founders of hemotune. With his very interdisciplinary background in microbiology, immunology and bioengineering he perfectly complements the hemotune team. During his studies at ETH Zurich, Carlos focused on the behavior and interaction of magnetic and non-magnetic nanoparticles in biological systems. He holds a Ph.D. WebNews & Updates about hemotune and research around sepsis. simple easy cute winter drawings
Carlos Mora - CSO and Co-Founder @ Hemotune - CrunchBase
WebApr 26, 2024 · Project Description. hemotune is developing the HemoSystem, a breakthrough medical device for acute-care blood purification. The first treatment under … Webhemotune AG 1,731 من المتابعين على LinkedIn. We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the … WebFounded Date 2016. Founders Carlos Mora, Lukas Langenegger. Operating Status Active. Last Funding Type Series B. Legal Name Hemotune AG. Company Type For Profit. … simple easy curse word color pages